9th July 2021
- 0 comments
Foresight Group, the award-winning listed private equity and infrastructure investment manager, has announced a £1.5m follow-on investment into portfolio company Biotherapy Services Ltd, a leading pharmaceutical biotech company. The funds will be used to support the clinical development of RAPIDTM Biodynamic Haematogel, currently in phase 2b/3 clinical trials in the treatment of DFUs.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage